CliffBio
small molecule

CALCIUM GLUCONATE IN SODIUM CHLORIDE

CALCIUM GLUCONATE

Loss of exclusivityJuly 2037latest FDA-listed patent expiry
CompanyFresenius Kabi →View the full company profile on CliffBio

Drug detail

Brand nameCALCIUM GLUCONATE IN SODIUM CHLORIDE
Active ingredientCALCIUM GLUCONATE
Strength2GM/100ML (20MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJune 2021
Marketing statusDISCN

Listed patents

PatentExpiresType
10130646July 2037product

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

CALCIUM GLUCONATE IN SODIUM CHLORIDE patent cliff — loss of exclusivity July 2037 | CliffBio